Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Healthcare | 9.78% |
| 3 | Financials | 9.01% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Allegion
ALLE
$14B
| $10.1M | ﹤0.01% |
80,093
-47,791
| -37% | -$5.52M |
|
|
PML
2627
PIMCO Municipal Income Fund II
PML
$495M
| $10M | ﹤0.01% |
675,010
-2,584
| -0.4% | -$37.8K |
|
2628
Cenovus Energy
CVE
$57.6B
| $10M | ﹤0.01% |
1,335,130
-2,276,637
| -63% | -$16M |
|
|
FLNA
2629
Filana Therapeutics
FLNA
$45.2M
| $10M | ﹤0.01% |
223,362
+172,250
| +337% | +$6.77M |
|
2630
Coherus Oncology
CHRS
$178M
| $10M | ﹤0.01% |
686,651
+110,457
| +19% | +$1.88M |
|
2631
Heron Therapeutics
HRTX
$63.3M
| $10M | ﹤0.01% |
618,728
+158,965
| +35% | +$2.83M |
|
2632
Sterling Infrastructure
STRL
$17.3B
| $10M | ﹤0.01% |
432,007
-84,605
| -16% | -$1.84M |
|
2633
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
| $10M | ﹤0.01% |
204,588
+74,570
| +57% | +$3.44M |
|
2634
iShares MSCI Norway ETF
ENOR
$102M
| $10M | ﹤0.01% |
361,051
+191,147
| +113% | +$5.09M |
|
2635
Grocery Outlet
GO
$1.04B
| $10M | ﹤0.01% |
271,244
+11,467
| +4% | +$445K |
|
2636
CVB Financial
CVBF
$4.07B
| $10M | ﹤0.01% |
452,642
-97,225
| -18% | -$2.11M |
|
2637
Helmerich & Payne
HP
$4.37B
| $9.99M | ﹤0.01% |
370,695
+15,398
| +4% | +$425K |
|
2638
MaxLinear
MXL
$7.24B
| $9.99M | ﹤0.01% |
293,148
+71,172
| +32% | +$2.54M |
|
2639
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $9.99M | ﹤0.01% |
311,421
-480,482
| -61% | -$15.7M |
|
2640
Clean Harbors
CLH
$16.9B
| $9.99M | ﹤0.01% |
118,839
+68,794
| +137% | +$5.79M |
|
|
ARNC
2641
DELISTED
Arconic Corporation
ARNC
| $9.94M | ﹤0.01% |
391,610
-99,107
| -20% | -$2.66M |
|
2642
Ligand Pharmaceuticals
LGND
$5.74B
| $9.94M | ﹤0.01% |
104,495
+29,997
| +40% | +$2.84M |
|
2643
Virtus Investment Partners
VRTS
$1.13B
| $9.93M | ﹤0.01% |
42,151
+5,399
| +15% | +$1.3M |
|
2644
Dorman Products
DORM
$3.94B
| $9.93M | ﹤0.01% |
96,692
-13,253
| -12% | -$1.32M |
|
|
XONE
2645
DELISTED
The ExOne Company
XONE
| $9.92M | ﹤0.01% |
316,413
+279,469
| +756% | +$8.8M |
|
|
SFBS
2646
ServisFirst Bancshares
SFBS
$5.02B
| $9.91M | ﹤0.01% |
161,548
-94,836
| -37% | -$4.71M |
|
|
IH
2647
iHuman
IH
$67.5M
| $9.91M | ﹤0.01% |
791,780
-133,445
| -14% | -$2.36M |
|
|
AIF
2648
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $9.91M | ﹤0.01% |
665,758
+32,737
| +5% | +$479K |
|
2649
NorthWestern Energy
NWE
$4.4B
| $9.89M | ﹤0.01% |
151,703
-50,732
| -25% | -$3M |
|
2650
Axos Financial
AX
$5.73B
| $9.88M | ﹤0.01% |
210,094
-17,016
| -7% | -$766K |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 189 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 189 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.